215 related articles for article (PubMed ID: 22844010)
1. Cushing's syndrome with adrenal suppression induced by inhaled budesonide due to a ritonavir drug interaction in a woman with HIV infection.
Yoganathan K; David L; Williams C; Jones K
Int J STD AIDS; 2012 Jul; 23(7):520-1. PubMed ID: 22844010
[TBL] [Abstract][Full Text] [Related]
2. Iatrogenic Cushing's syndrome in HIV-infected patients receiving ritonavir and inhaled fluticasone: description of 4 new cases and review of the literature.
Valin N; De Castro N; Garrait V; Bergeron A; Bouche C; Molina JM
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(2):113-21. PubMed ID: 19270151
[TBL] [Abstract][Full Text] [Related]
3. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature.
Foisy MM; Yakiwchuk EM; Chiu I; Singh AE
HIV Med; 2008 Jul; 9(6):389-96. PubMed ID: 18459946
[TBL] [Abstract][Full Text] [Related]
4. Iatrogenic Cushing's syndrome in an HIV-infected patient treated with inhaled corticosteroids (fluticasone propionate) and low dose ritonavir enhanced PI containing regimen.
Clevenbergh P; Corcostegui M; Gérard D; Hieronimus S; Mondain V; Chichmanian RM; Sadoul JL; Dellamonica P
J Infect; 2002 Apr; 44(3):194-5. PubMed ID: 12099750
[TBL] [Abstract][Full Text] [Related]
5. Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient.
Kedem E; Shahar E; Hassoun G; Pollack S
J Asthma; 2010 Sep; 47(7):830-1. PubMed ID: 20653496
[TBL] [Abstract][Full Text] [Related]
6. Inhaled fluticasone causes iatrogenic cushing's syndrome in patients treated with Ritonavir.
Mahlab-Guri K; Asher I; Gradstein S; Zung A; Radian-Sade S; Elbirt D; Sthoeger Z
J Asthma; 2011 Oct; 48(8):860-3. PubMed ID: 21854345
[TBL] [Abstract][Full Text] [Related]
7. Iatrogenic Cushing Syndrome in a 47-Year-Old HIV-Positive Woman on Ritonavir and Inhaled Budesonide.
Colpitts L; Murray TB; Tahhan SG; Boggs JP
J Int Assoc Provid AIDS Care; 2017; 16(6):531-534. PubMed ID: 29108449
[TBL] [Abstract][Full Text] [Related]
8. Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases.
Samaras K; Pett S; Gowers A; McMurchie M; Cooper DA
J Clin Endocrinol Metab; 2005 Jul; 90(7):4394-8. PubMed ID: 15755851
[TBL] [Abstract][Full Text] [Related]
9. [Exogenous Cushing's syndrome as a serious side-effect of therapy with ritonavir an inhaled fluticasone].
Machala L; Kréze A; Jilich D; Rozsypal H
Klin Mikrobiol Infekc Lek; 2011 Jun; 17(3):103-5. PubMed ID: 21780031
[TBL] [Abstract][Full Text] [Related]
10. Cushing's syndrome and severe adrenal suppression in patients treated with ritonavir and inhaled nasal fluticasone.
Chen F; Kearney T; Robinson S; Daley-Yates PT; Waldron S; Churchill DR
Sex Transm Infect; 1999 Aug; 75(4):274. PubMed ID: 10615321
[No Abstract] [Full Text] [Related]
11. Role of fluconazole in a case of rapid onset ritonavir and inhaled fluticasone-associated secondary adrenal insufficiency.
St Clair K; Maguire JD
Int J STD AIDS; 2012 May; 23(5):371-2. PubMed ID: 22648897
[TBL] [Abstract][Full Text] [Related]
12. Iatrogenic Cushing syndrome in patients receiving inhaled budesonide and itraconazole or ritonavir: two cases and literature review.
Blondin MC; Beauregard H; Serri O
Endocr Pract; 2013; 19(6):e138-41. PubMed ID: 23807527
[TBL] [Abstract][Full Text] [Related]
13. Adrenal insufficiency and exogenous Cushing's syndrome in a patient receiving inhaled fluticasone and ritonavir.
Zubillaga I; Francés C; Nicolau J; Homar F; Masmiquel L
Endocrinol Diabetes Nutr; 2017; 64(6):338-339. PubMed ID: 29056281
[No Abstract] [Full Text] [Related]
14. Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent.
St Germain RM; Yigit S; Wells L; Girotto JE; Salazar JC
AIDS Patient Care STDS; 2007 Jun; 21(6):373-7. PubMed ID: 17594245
[TBL] [Abstract][Full Text] [Related]
15. Adrenal suppression and Cushing's syndrome secondary to ritonavir and budesonide.
Gray D; Roux P; Carrihill M; Klein M
S Afr Med J; 2010 May; 100(5):296-7. PubMed ID: 20460021
[No Abstract] [Full Text] [Related]
16. Iatrogenic Cushing syndrome after intra-articular triamcinolone in a patient receiving ritonavir-boosted darunavir.
Hall JJ; Hughes CA; Foisy MM; Houston S; Shafran S
Int J STD AIDS; 2013 Sep; 24(9):748-52. PubMed ID: 23970582
[TBL] [Abstract][Full Text] [Related]
17. Iatrogenic Cushing's syndrome after triamcinolone plus ritonavir-boosted atazanavir.
Jakeman B; Conklin J; Bouchonville M; Thornton K
J Am Pharm Assoc (2003); 2015; 55(2):193-7. PubMed ID: 25658506
[TBL] [Abstract][Full Text] [Related]
18. Cushing's syndrome due to interaction between inhaled corticosteroids and itraconazole.
Bolland MJ; Bagg W; Thomas MG; Lucas JA; Ticehurst R; Black PN
Ann Pharmacother; 2004 Jan; 38(1):46-9. PubMed ID: 14742792
[TBL] [Abstract][Full Text] [Related]
19. [Fluticasone-ritonavir: a drug-drug interaction causing iatrogenic Cushing's syndrome and adrenal insufficiency].
Rousseau C; Dolz M
Med Mal Infect; 2014 Oct; 44(10):483-4. PubMed ID: 25282607
[No Abstract] [Full Text] [Related]
20. Cushing syndrome with secondary adrenal insufficiency from concomitant therapy with ritonavir and fluticasone.
Johnson SR; Marion AA; Vrchoticky T; Emmanuel PJ; Lujan-Zilbermann J
J Pediatr; 2006 Mar; 148(3):386-8. PubMed ID: 16615973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
